UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549~~

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT ~~Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934~~

~~Date~~Pursuant ofto ~~Report~~Section 13 or 15(~~Date~~d) of ~~earliest~~the ~~reported):~~Securities ~~August~~Exchange ~~17, 2009~~Act of 1934

~~WELLQUEST~~Date ~~MEDICAL~~of &Report ~~WELLNESS CORPORATION~~ (~~Exact~~Date ~~name~~ of ~~registrant~~earliest asreported): April ~~specified~~5, ~~in charter)~~2010

Oklahoma				333-149260				20-1842879
(State or other jurisdiction of incorporation)				(Commission File Number)				(IRS Employer Identification No.)

WELLQUEST MEDICAL & WELLNESS CORPORATION

3400 SE Macy Rd, #18, Bentonville, Arkansas				72712
(Address of principal executive offices)				(Zip Code)

(Exact name of registrant as specified in charter)

Oklahoma
(State or other jurisdiction
of incorporation)

333-149260
(Commission
File Number)

20-1842879
(IRS Employer
Identification No.)

3400 SE Macy Rd, #18, Bentonville, Arkansas 72712

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (479) 845-0880

Copies to: ~~Gregory Sichenzia, Esq. James M. Turner, Esq. Sichenzia Ross Friedman Ference LLP 61 Broadway New York, New York 10006 Phone: (212) 930-9700 Fax: (212) 930-9725~~

Gregory Sichenzia, Esq.

James M. Turner, Esq.

Sichenzia Ross Friedman Ference LLP

61 Broadway

New York, New York 10006

Phone: (212) 930-9700

Fax: (212) 930-9725

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

~~[ ]~~o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~[ ]~~o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

~~[ ]~~o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

~~[ ]~~o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 2.02

Results of Operations and Financial Condition

On ~~August~~April 175, ~~2009~~2010, the Company announced its operating results for the ~~second~~ fiscal ~~quarter~~year ended ~~June~~December 3031, 2009. A copy of the press release that discusses this matter is filed as Exhibit 99.1 to, and incorporated by reference in, this report. The information in this Current Report is being furnished and shall not be deemed “"filed”" for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, except as shall be expressly set forth by specific reference in any such filing.

ITEM 9.01

Financial Statements and Exhibits.

(d)

Exhibits.

99.1 Press Release, dated ~~August~~April 175, ~~2009~~2010, issued by WellQuest Medical & Wellness Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WELLQUEST MEDICAL & WELLNESS CORPORATION Dated: August 17, 2009 BY: /s/ GREG PRIMM Greg Primm Chief Financial Officer

	WELLQUEST MEDICAL & WELLNESS CORPORATION

Dated: April 5, 2010	BY:	/s/ GREG PRIMM
		Greg Primm Chief Financial Officer

Filing Compare · WELLQUEST MEDICAL & WELLNESS CORP